Your browser doesn't support javascript.
loading
Hepatic Encephalopathy Caused by Long-Term Amiodarone Use.
Murata, Naoki; Nishizawa, Toshinori; Kim, Yuntae; Arioka, Hiroko.
Afiliación
  • Murata N; Department of General Internal Medicine, St. Luke's International Hospital, Tokyo, JPN.
  • Nishizawa T; Department of General Internal Medicine, St. Luke's International Hospital, Tokyo, JPN.
  • Kim Y; Department of Gastroenterology, St. Luke's International Hospital, Tokyo, JPN.
  • Arioka H; Department of General Internal Medicine, St. Luke's International Hospital, Tokyo, JPN.
Cureus ; 15(12): e50690, 2023 Dec.
Article en En | MEDLINE | ID: mdl-38229783
ABSTRACT
This case describes a 72-year-old Japanese woman with hypertrophic cardiomyopathy and non-sustained ventricular tachycardia who had received a total of 215 g of amiodarone over six years and presented with hepatic encephalopathy. The abdominal non-contrast computed tomography showed diffusely increased attenuation of the liver parenchyma. The liver biopsy revealed drug-induced steatohepatitis. No genetic variations in the urea cycle were found. She was ultimately diagnosed with drug-induced steatohepatitis and urea cycle abnormalities caused by long-term amiodarone use. Amiodarone may cause drug-induced steatohepatitis and urea cycle abnormalities, which could induce hyperammonemia. Although case reports of amiodarone-induced hyperammonemia and hepatic encephalopathy have already been reported, we present a typical picture of an amiodarone-induced bright liver, including the mechanism of amiodarone-induced hyperammonemia, to provide an educational learning point for many readers.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cureus Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cureus Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos